218 related articles for article (PubMed ID: 7286196)
1. [Effect of noradrenaline and angiotensin II on the brain and kidney blood supply with changes in systemic arterial pressure].
Beketov AI; Korneliuk IK
Farmakol Toksikol; 1981; 44(4):414-7. PubMed ID: 7286196
[TBL] [Abstract][Full Text] [Related]
2. [Effect of intravenous administration of noradrenaline and angiotensin on blood supply to the brain, kidneys, intestine and hindlimbs of cats].
Beketov AI; Demchenko IT; Korneliuk IK; Moskalenko IuE
Fiziol Zh SSSR Im I M Sechenova; 1981 Aug; 67(8):1245-50. PubMed ID: 7286339
[No Abstract] [Full Text] [Related]
3. Effect of angiotensin-converting enzyme two-week inhibition on renal angiotensin II receptors and renal vascular reactivity in SHR.
Haddad G; Garcia R
J Mol Cell Cardiol; 1997 Feb; 29(2):813-22. PubMed ID: 9140837
[TBL] [Abstract][Full Text] [Related]
4. Role of the renal nerves and angiotensin II in the renal function curve.
Golin R; Genovesi S; Castoldi G; Wijnmaalen P; Protasoni G; Zanchetti A; Stella A
Arch Ital Biol; 1999 Aug; 137(4):289-97. PubMed ID: 10443320
[TBL] [Abstract][Full Text] [Related]
5. Effect of vasoactive agents on the distribution of renal cortical blood flow in dogs.
Tyssebotn I; Kirkebo A
Acta Physiol Scand; 1975 Nov; 95(3):318-28. PubMed ID: 1189939
[TBL] [Abstract][Full Text] [Related]
6. Role of adenosine A(1) receptor in angiotensin II- and norepinephrine-induced renal vasoconstriction.
Aki Y; Nishiyama A; Miyatake A; Kimura S; Kohno M; Abe Y
J Pharmacol Exp Ther; 2002 Oct; 303(1):117-23. PubMed ID: 12235241
[TBL] [Abstract][Full Text] [Related]
7. [Cerebral vascular reactivity of cats with chronic hypertension].
Krasil'nikov VG; Gnüchtel U; Zeschke G; Nichkov S
Patol Fiziol Eksp Ter; 1981; (6):39-44. PubMed ID: 7322629
[No Abstract] [Full Text] [Related]
8. Effects of renal perfusate flow on systemic blood pressure in the rat [proceedings].
Woodward B
J Physiol; 1978 Apr; 277():80P. PubMed ID: 650591
[No Abstract] [Full Text] [Related]
9. [Effect of the sympathetic nervous system on changes in the resistance of the hemato-encephalic barrier in arterial hypertension].
Tashaev ShS
Biull Eksp Biol Med; 1983 Apr; 95(4):9-11. PubMed ID: 6831029
[TBL] [Abstract][Full Text] [Related]
10. Pressor and intra-renal effects of angiotensins I and II, and noradrenaline, in anaesthetized and conscious sheep. The effects of halothane anaesthesia on pressor sensitivity and electrolyte shifts: the proposed use of angiotensin I in treating septicaemia and septic shock.
Duckworth AJ; Goodship AE; Kendall HJ; Osborn EC
Med Hypotheses; 2005; 64(4):833-47. PubMed ID: 15694705
[TBL] [Abstract][Full Text] [Related]
11. Vascular reactivity to angiotensin II is selectively enhanced in the kidneys of spontaneously hypertensive rats.
Kost CK; Herzer WA; Li P; Jackson EK
J Pharmacol Exp Ther; 1994 Apr; 269(1):82-8. PubMed ID: 8169855
[TBL] [Abstract][Full Text] [Related]
12. Comparison of haemodynamic effects of equipressor doses of intravenous angiotensin and noradrenaline in man.
Brod J; Hejl Z; Hornych A; Jirka J; Slechta V; Buriánová B
Clin Sci; 1969 Apr; 36(2):161-72. PubMed ID: 4307416
[No Abstract] [Full Text] [Related]
13. Further studies on noradrenaline postinfusional hypotension.
Mazurkiewicz IM
Arch Int Pharmacodyn Ther; 1967 Jul; 168(1):36-54. PubMed ID: 4292762
[No Abstract] [Full Text] [Related]
14. [Comparative analysis of the changes in the organic blood flow in the brain, kidneys, intestines and hindlimbs of cats as affected by adrenaline and noradrenaline].
Beketov AI; Korneliuk IK
Farmakol Toksikol; 1987; 50(2):33-6. PubMed ID: 3582630
[TBL] [Abstract][Full Text] [Related]
15. [Use of angiotensin II to control systemic arterial pressure].
Pugovkin AP; Kalikhevich VN; Ardemasova ZA; Osadchiĭ LI
Fiziol Zh SSSR Im I M Sechenova; 1981 Nov; 67(11):1733-6. PubMed ID: 7327283
[No Abstract] [Full Text] [Related]
16. Reduction of the pressor response to angiotensin and norepinephrine in the rat, induced by a renal peptide.
Fasciolo JC; Risler NR
Acta Physiol Lat Am; 1973; 23(6):521-2. PubMed ID: 4369126
[No Abstract] [Full Text] [Related]
17. Dietary salt intake, blood pressure and the kidney in hypertensive patients with non-insulin dependent diabetes mellitus.
Campese VM; Wurgaft A; Safa M; Bianchi S
J Nephrol; 1998; 11(6):289-95. PubMed ID: 10048494
[TBL] [Abstract][Full Text] [Related]
18. Treatment with the type IV phosphodiesterase inhibitor Ro 20-1724 protects renal and mesenteric blood flow in endotoxemic rats treated with norepinephrine.
Carcillo JA; Herzer WA; Mi Z; Thomas NJ; Jackson EK
J Pharmacol Exp Ther; 1996 Dec; 279(3):1197-204. PubMed ID: 8968341
[TBL] [Abstract][Full Text] [Related]
19. Brain and peripheral angiotensin II type 1 receptors mediate renal vasoconstrictor and blood pressure responses to angiotensin IV in the rat.
Yang R; Smolders I; De Bundel D; Fouyn R; Halberg M; Demaegdt H; Vanderheyden P; Dupont AG
J Hypertens; 2008 May; 26(5):998-1007. PubMed ID: 18398343
[TBL] [Abstract][Full Text] [Related]
20. The hemodynamic importance of structural vascular changes in essential hypertension.
Sivertsson R
Acta Physiol Scand Suppl; 1970; 343():1-56. PubMed ID: 4319537
[No Abstract] [Full Text] [Related]
[Next] [New Search]
